Modus Create achieves AWS Life Sciences Competency status

RESTON, Va.–(BUSINESS WIRE)– Modus Create, a global digital consultancy specializing in product engineering, today announced it has achieved Amazon Web Services (AWS) Life Sciences Competency status. This designation recognizes Modus Create for its demonstrated expertise in delivering secure, cloud-native solutions that help pharmaceutical and life sciences organizations accelerate innovation, modernize infrastructure, and reduce time-to-market for critical therapies. Modus is one of only 36 AWS Consulting Partners globally to hold this competency.

The AWS Life Sciences Competency differentiates Modus Create as an AWS Partner with validated technical proficiency, regulatory alignment, and a strong record of customer success. To earn the designation, AWS Partners must demonstrate deep domain expertise and the ability to deliver measurable outcomes across drug discovery, clinical development, and commercialization.

A recent project that Modus Create developed which reinforces its expertise in digital and AI transformation was the launch of EVERSANA ORCHESTRATE™ MLR, built for EVERSANA, a leading provider of commercial services to the life sciences industry. The solution reduces the medical, legal, and regulatory review process timelines by nearly 50%.

“The AI-expertise of the Modus Create team, together with AWS, enabled us to build a compliant, scalable solution to meet the growing needs of our customers,” said Faruk Capan, Chief Innovation Officer, EVERSANA.

AWS is enabling scalable, flexible, and cost-effective solutions from startups to global enterprises. To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify AWS Partners with deep industry experience and expertise.

Modus Create helps life sciences organizations modernize legacy platforms, implement compliant generative AI, and streamline global operations through secure, data-driven architectures. Its cloud solutions are designed for scalability, interoperability, and regulatory compliance – enabling customers to accelerate time-to-insight and unlock high-value AI use cases across the enterprise.

“Earning the AWS Life Sciences Competency designation is a huge accomplishment and a testament to the dedication and expertise of Modus Create’s product engineering teams and how they are helping pharmaceutical and life sciences companies revolutionize the industry,” said Sarah McCasland, Chief Strategy Officer at Modus Create. “By helping these enterprises become digital-first organizations through harnessing AI and cloud technologies with AWS, our life sciences clients can accelerate their Pharma 4.0 initiatives to drive innovation and business growth.”

With experience serving both early-stage biotechs and global pharmaceutical enterprises, Modus Create offers specialized AWS services for the life sciences sector. These include generative AI enablement, data modernization, cloud infrastructure optimization, and secure digital product development. As an AWS Advanced Tier Services Partner and active AWS Marketplace provider, Modus aligns technical execution with strategic priorities to help life sciences customers deliver better outcomes, faster.

Working in pharma or life sciences and evaluating AWS partners? See how Modus Create combines AWS expertise with deep life sciences knowledge to accelerate your transformation.